Research: Liraglutide: Weight Loss, Dosing, & Safety Info

Discover the benefits of Liraglutide, a GLP-1 receptor agonist for weight loss and diabetes, now available in generic form. Learn about dosing, effects, and research findings.

Liraglutide: Weight Loss, Dosing, & Safety Info Research Papers & Clinical Studies

Liraglutide: Weight Loss, Dosing, & Safety Info is a peptide studied for its potential therapeutic effects. Discover the benefits of Liraglutide, a GLP-1 receptor agonist for weight loss and diabetes, now available in generic form. Learn about dosing, effects, and research findings. This page indexes all published research papers, clinical trials, and scientific studies related to Liraglutide: Weight Loss, Dosing, & Safety Info that are available in the PepsReview research library. Each paper includes metadata such as journal name, publication year, citation count, study type, and a summary of key findings. Where available, we provide direct links to the original publication and DOI references.

Researchers can use this index to quickly locate evidence supporting specific Liraglutide: Weight Loss, Dosing, & Safety Info applications, compare study designs, and evaluate the strength of clinical evidence. Papers are sorted by relevance and citation count. There are currently 5 research papers indexed for Liraglutide: Weight Loss, Dosing, & Safety Info.

For vendor pricing, user reviews, and a complete peptide profile including mechanism of action, benefits, side effects, and regulatory status, visit the main Liraglutide: Weight Loss, Dosing, & Safety Info profile page.

Liraglutide: Weight Loss, Dosing, & Safety Info
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial
JAMA 2015 1650 Clinical Trial
SCALE Diabetes trial: liraglutide 3.0mg achieved significant weight loss in adults with type 2 diabetes and overweight/obesity compared to placebo.
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
N Engl J Med 2015 1650 Clinical Trial
Randomized controlled trial of liraglutide 3.0mg for weight management, demonstrating efficacy for sustained weight loss in adults with overweight or obesity.
Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined
N Engl J Med 2021 750 Clinical Trial
After 8-week low-calorie diet, liraglutide plus exercise maintained weight loss best over 1 year compared to either intervention alone in adults with obesity.
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial
JAMA 2022 600 Clinical Trial
STEP 8 trial: once-weekly semaglutide 2.4mg produced greater weight loss than daily liraglutide 3.0mg over 68 weeks in adults with overweight or obesity.
Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial
N Engl J Med 2025 200 Clinical Trial
Randomized trial evaluating liraglutide for weight management in children aged 6 to <12 years with obesity, assessing efficacy and safety in pediatric patients.